Filing Details

Accession Number:
0001179110-10-016948
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-03 12:00:00
Reporting Period:
2010-12-01
Filing Date:
2010-12-03
Accepted Time:
2010-12-03 19:15:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302445 L David Brinkley Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Head Of Business Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-01 15,275 $3.10 58,359 No 4 M Direct
Common Stock Disposition 2010-12-01 20,000 $25.07 38,359 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-12-01 15,275 $0.00 15,275 $3.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,789 2013-01-24 No 4 M Direct
Footnotes
  1. Immediately exercisable.